Planning Around Huntington’s Disease in a Family

Question 1: “Have You Had Genetic Testing?” — Asked by Every Insurance Underwriter

This is the question that has to be understood before it is answered, because the answer is irreversible.

What a good answer requires knowing first: the Genetic Information Nondiscrimination Act of 2008 (GINA) prohibits the use of genetic information in health insurance and in employment. It does not cover life insurance, disability insurance, or long-term care insurance. In most states, as of 2026, a life insurer may lawfully ask whether you have had predictive genetic testing and may consider the result. A small number of states have gone further — Florida enacted a law in 2020 restricting life, disability and long-term care insurers’ use of genetic test results — but most have not. Confirm your own state’s rule with the state department of insurance, because this is an active legislative area.

The practical sequence most genetic counselors and elder law attorneys describe: decide what coverage the household needs, apply for and place that coverage, and only then decide about predictive testing. Reversing those two steps closes a door permanently. Note the boundary — an existing in-force policy cannot be repriced or cancelled because of a later test result, once the contestability period has passed. What is at risk is future coverage, not coverage already in force.

A good answer to the underwriter’s question is simply truthful. Misrepresenting a known test result on an application is exactly the kind of thing that gets a claim contested later, which defeats the purpose of buying the policy.

Question 2: “When Did Symptoms Begin?” — Asked by Social Security

Adult-onset Huntington’s disease is on the Social Security Administration’s Compassionate Allowances list, which routes qualifying claims to expedited processing. Juvenile Huntington’s disease is listed separately. Being on the list does not make approval automatic; it makes the review faster when the medical evidence is clear.

What SSA is actually asking for is a documented onset date and objective findings. A good answer is built from: the neurologist’s records showing motor findings, the confirmed genetic test result if one exists, functional evidence about work capacity, and a clear date the person stopped or reduced work.

Two timing facts drive the household’s cash flow. Social Security Disability Insurance has a five-month waiting period from the established onset of disability before benefits begin. Medicare entitlement for an SSDI recipient generally begins 24 months after SSDI entitlement starts — that is roughly a 29-month gap from disability onset to Medicare, which is the single largest planning problem for a family in their forties or fifties. Confirm both against your own SSA notice, because the established onset date SSA assigns is what drives them, not the date you believe symptoms started.

Bridging that gap is where an employer plan continuation, a marketplace plan with subsidies, a spouse’s plan, or Medicaid does the work. The state Medicaid agency and a State Health Insurance Assistance Program (SHIP) counselor are the two free places to model it.

Question 3: “Who Is Paying for Care, and From What?” — Asked by Facilities

Huntington’s is expensive for an unusual reason: the person needing care is often decades younger than a typical long-term care resident, and the care period is long. Published clinical sources commonly describe survival of roughly 10 to 25 years from motor onset, with chorea, cognitive change and swallowing difficulty progressing on separate timelines. That is a very different funding problem from a two-year late-life nursing home stay.

For 2026 cost planning, use a published survey rather than a guess. The Genworth Cost of Care Survey’s most recently published national medians run roughly $5,900 a month for assisted living, roughly $9,300 for a semi-private nursing home room and roughly $10,600 for a private room, with wide state-to-state variation. Treat those as a range, not a quote, and price your own metropolitan area — a state cost-of-care survey or a call to three local facilities will beat any national median.

Then note the coverage boundary that catches families off guard: Medicare pays for skilled nursing care after a qualifying hospital stay for a limited benefit period, not for long-term custodial supervision. Medicaid is the main public payer for custodial care, and its rules on countable assets, including life insurance cash value, are where planning either works or fails. Our page on planning for memory-related care costs covers the same arithmetic for cognitive decline.

Many families also use a written personal care agreement to pay a relative for care. Do it properly or not at all; see how to pay a family caregiver legally.

Who is asking	The question	What a good answer contains	Confirm with
Life or LTC underwriter	Have you had predictive genetic testing?	Truthful answer; know that GINA does not cover life, disability or LTC insurance	State department of insurance
Social Security	When did symptoms begin?	Neurology records, onset date, work-capacity evidence; Compassionate Allowances listing	SSA
Facility admissions	What is the funding source?	Private pay runway, LTC policy, Medicaid application status	Facility business office
Medicaid caseworker	Does the applicant own life insurance?	Face amount and cash surrender value for every policy	State Medicaid agency
Carrier service line	Who is authorized to act?	Durable POA with express insurance powers, on the carrier’s own form	Carrier, in writing
Settlement underwriter	Is the insured symptomatic?	Current clinical records; asymptomatic gene carriers rarely produce offers	A broker or provider review

Question 4: “Does the Insured Own Any Life Insurance?” — Asked by Medicaid

A Medicaid caseworker will ask this, and the honest answer requires you to know two numbers: the face amount and the cash surrender value.

The general federal framework works like this. Term life insurance has no cash value and is generally not a countable resource. Permanent policies are treated differently: under the long-standing rule applied in most states, if the total face value of policies on one person is at or below $1,500, the cash value is excluded; if the total face value exceeds that threshold, the cash surrender value is generally counted as an available resource. Several states set their own figures and a few have eliminated the asset test entirely. As of 2026 confirm the current threshold and treatment with the state Medicaid agency directly — this is exactly the kind of number that goes stale.

What that means in practice: a permanent policy with meaningful cash value can block eligibility until it is dealt with, and how it is dealt with matters. Surrendering it, selling it, or converting the proceeds into an irrevocable funeral arrangement have different consequences under the 60-month look-back rules found in the federal Medicaid transfer provisions. Do not improvise this. An elder law attorney in the state where the applicant lives is the person for this decision — when to bring in an elder law attorney describes the trigger points.

Question 5: “Would You Consider Selling the Policy?” — And When the Answer Should Be No

Sometimes an in-force policy is the most liquid asset a Huntington’s household owns, and a secondary-market sale converts it into care funding years before a death benefit would arrive. Sometimes it is the worst thing the family could do. The difference is not subtle.

Selling is likely wrong when: the face amount is small — the market generally has little interest below roughly $100,000 of death benefit; the policy is a burial or final-expense policy already sitting inside a benefits exclusion; the insured is the at-risk but still asymptomatic family member in good health, which pushes any valuation down to almost nothing; a spouse or a dependent child, especially a child who may also carry the expansion, still needs the death benefit; or the household could instead reduce coverage, use a paid-up option, or tap an accelerated death benefit rider already in the contract at no cost.

Selling is worth investigating when: the insured is symptomatic, the premium is no longer affordable and the alternative is a lapse for nothing, the face amount is substantial, and no one is depending on the death benefit. A lapse pays the family zero; that is the real comparison.

Because Huntington’s is hereditary, one more wrinkle applies. If a family is considering keeping coverage inside a trust for a child who may later develop symptoms, the trust structure and the sale question interact — see how a sale interacts with trust-owned coverage before doing either. And if the buyer would be a relative rather than the open market, read selling a policy to a family member first, because that transaction has its own tax and valuation traps.

Question 6: “Who Speaks for This Person?” — Asked by Everyone, Eventually

Huntington’s affects judgment and executive function, not just movement, and it does so gradually. Every institution the family deals with will eventually need to know who is authorized to act.

Get four documents executed while capacity is unquestioned: a durable power of attorney with express authority over insurance matters, a health care proxy or medical power of attorney, a HIPAA authorization naming the people who may receive medical information, and an up-to-date will. The insurance-specific point that families miss: a general durable power of attorney often does not clearly authorize an agent to change a beneficiary, surrender a policy, or sell one. Carriers read those powers narrowly and reject agents who lack express authority.

Capacity is also a live issue for any policy transaction. A notary is obligated to decline if a signer appears not to understand the document, and a life settlement provider will independently want evidence of capacity and of the absence of coercion. That is a protection, not an obstacle, but it means the paperwork window has a closing date.

If a policy review is on your list, the least-committal version is to send the policy cover page and current premium notice for a free look at whether the contract has any market value at all, or call (732) 978-9575. Expect a straight answer, including "this one is not a candidate," which is a common and useful outcome. For a broader view of what a sale even is, start with the basics of a life settlement.

---

Frequently Asked Questions

Can a life insurer use a Huntington’s genetic test result against me?

In most states as of 2026, yes. The federal Genetic Information Nondiscrimination Act covers health insurance and employment only; life, disability and long-term care insurance sit outside it. A small number of states, including Florida since 2020, restrict insurers’ use of genetic test results. Confirm your state’s rule with the state department of insurance before testing.

If I already own a policy and then test positive, can the insurer cancel it?

No. An in-force policy past its contestability period cannot be repriced or rescinded because of a later test result, provided the original application was truthful. What a positive result affects is your ability to buy new coverage. This is why sequencing matters: place the coverage the household needs first, then make the testing decision.

How long is the wait for Medicare after a disability approval?

Social Security Disability Insurance has a five-month waiting period from the established onset date, and Medicare entitlement generally begins 24 months after SSDI entitlement starts. That produces a gap of roughly 29 months from onset. Bridge it with an employer plan, a marketplace plan, a spouse’s coverage or Medicaid, and confirm your dates on your own SSA notice.

Will an in-force policy stop a Medicaid application?

It can. Term insurance generally has no cash value and is usually not counted. For permanent policies, most states apply a face-value threshold, commonly $1,500 of total face value per insured, above which the cash surrender value is counted as an available resource. Thresholds and rules differ by state and change, so confirm with the state Medicaid agency.

Is selling a policy a good idea for an at-risk family member who has no symptoms?

Almost never. Secondary-market pricing tracks impaired life expectancy, so a healthy, asymptomatic adult in their thirties or forties will draw either no offer or a very low one, and would be giving up coverage that is difficult to replace. The stronger move is usually to keep the coverage and revisit the question only if symptoms progress.

What does long-term care actually cost for someone with Huntington’s?

Use published survey ranges rather than a single figure. The Genworth Cost of Care Survey’s recent national medians run roughly $5,900 a month for assisted living and roughly $9,300 to $10,600 for nursing home care, varying widely by state. Because the care period can span many years, price your own area and confirm current figures directly with facilities.

Related Reading

• Multiple Sclerosis Progression Planning
• Life Settlement Vs Ilit Planning
• Selling Policy To Family Member
• Second Marriage Blended Family
• Memory Care Cost Planning
• Paying A Family Caregiver Legally
• What Is A Life Settlement
• Elder Law Attorney When To Involve

---

Pine Lake Legacy does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.